EFFICIENCY OF NEUROMETABOLIC THERAPY AMONG THE PATIENTS WITH ISCHEMIC HEMISPHERIC STROKE IN RECOVERY PERIOD

Authors

  • O. A. Kozyolkin Zaporizhzhia State Medical University
  • S. O. Medvedkova Zaporizhzhia State Medical University, Zaporizhzhia, Ukraine
  • A. A. Kuznietsov Zaporizhzhia State Medical University, Zaporizhzhia, Ukraine

DOI:

https://doi.org/10.11603/2415-8798.2019.1.9939

Keywords:

stroke, recovery period, rehabilitation

Abstract

Cerebrovascular diseases, and especially their acute forms, cerebral strokes, are an important problem in modern medicine. The search and usage of new and more effective drugs, which contribute to the improvement of treatment results in the recovery period of the disease, are relevant.

The aim of the study – to improve the treatment of patients with cerebral ischemic stroke in the recovery period by using phenylpiracetam in the complex therapy.

Materials and Methods. The work presents the results of treatment of 70 patients (average age is (58.8±0.9) years) in the recovery period of ischemic hemispheric stroke (IHS). All the patients were divided into two clinical groups of 35 patients. The group 1 included the patients who received phenylpiracetam in a complex therapy orally in a daily dose of 200 mg, divided into 2 intakes: in the morning and at lunch for 30 days; the group 2 consisted of patients who received piracetam as a nootropic drug parenterally in a daily dose of 3000 mg once in the morning during 30 days. All the patients were carried out in the dynamics before the treatment and after 30 days the assessment of the state according to the stroke scale of the National Institute of Health in order to determine the severity of the stroke. The degree of functional restoration according to Modified Rankin Scale and the estimation of the ability of household skills and self-service according to the Barthel Index were determined. A dynamic evaluation of cognitive impairments was performed using the Mini-Menthal State Examination and the 10-word memory test.

Results and Discussion. As a result of treatment, positive dynamics of all clinical-neurological and cognitive indicators was observed, it was more revealed in patients of the main group using phenylpiracetam, compared with the control group (p<0.05). In the main group, after the therapy, MMSE points increased by 13.0 % (p˂0.01) due to the improvement of most cognitive domains: memory in 2 times (p˂0.01), attention and calculation – by 33.3 % (p˂0.01), orientation – by 12.5 % (p˂0.01).  In the control group it was registered statistically significant but less revealed, in comparison with the main group, the increasing of points according to MMSE (Δ% + 4.2 %, p˂0.01).

Conclusions. The conducted research informs us about positive effects of the phenylpiracetam drug, which contribute to the improvement of treatment outcome among the patients with IHS in the recovery period.

References

Voloshнn, P.V., & Maruta, N.O. (2017). Osnovni napryamky naukovykh rozrobok v nevrolohiyi, psykhiatriyi ta narkolohiyi v Ukrayini [The main areas of scientific development in neurology, psychiatry and narcology in Ukraine]. Ukr. visnyk psykhonevrolohii – Ukr. Journal of Psychoneurology, 25, 1 (90), 10-18 [in Ukrainian].

Shkrobot, S.I., Sokhor, NR., Milevska-Vovchuk, LS., Krynytska, I.Ya., Marushchak, M.I., Shkrobot, L.V., & Yasnij, O.R. (2018). Clinical neurological characteristics of ischemic stroke subtypes in acute phase. Zaporozhye medical journal, 20 (1), 41-46.

Mishchenko, TS. (2017). Osnovni napriamky naukovykh rozrobok v nevrolohii, psykhiatrii ta narkolohii v Ukraini [Epidemiology of cerebrovascular diseases and organization of medical care for patients with stroke in Ukraine]. Ukrainskyi visnyk psykhonevrolohii – Ukr. Journal of Psychoneurology, 25, 1 (90), 22-24 [in Ukrainian].

Westerlind, E., Persson, H.C., & Sunnerhagen, K.S. (2017). Return to Work after a Stroke in Working Age Persons; A Six-Year Follow Up. PLoS One, 6, 12 (1), e0169759. doi: 10.1371/journal.pone.0169759.

Lahiff-Jenkins, C. (2014). We invite you to comment: The WSO Stroke Research Committee research recommendations relevant to the WSOmission for stroke treatment, prevention and recovery. World Stroke Organization Blogspot. URL : http://worldstrokeorganization.blogspot.com.au/2014/12/we-invite-you-to-comment-wso-stroke.html.

Winstein, C.J., Stein, J., Arena, R., Bates, B., Cherney, L.R., Cramer, S.C., … & Zorowitz, R.D. (2016). Guidelines for adult stroke rehabilitation and recovery: A guideline for healthcare professionals from the American Heart Association. Am. Stroke Association. Stroke, 47, 98-169.

Akhapkina, V.I., & Akhapkin, R.V. (2013). Identification and evaluation of the neuroleptic activity of phenotropil. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 7, 42-46.

Hara, Y. (2015). Brain plasticity and rehabilitation in stroke patients. J. Nippon Med. School, 82 (1), 4-13.

Thomas, L.H., French, B., Coupe, J., McMahon, N., Connell, L., Harrison, J., … & Watkins, C.L. (2017). Repetitive Task Training for Improving Functional Ability After Stroke: A Major Update of a Cochrane Review. Stroke, 48, e102-e103.

Bagir, L.V., Batysheva, T.T., Boyko, A.N., Kostenko, Ye.V., Manevich, T.M., & Matviyevskaya, O.V. (2006). Primeneniye fenotropila pri nalichii ambulatornykh bolnykh v rannem vosstanovlennom periode ishemicheskogo insulta [The using fenotropil in the treatment of outpatients in the early recovery period of ischemic stroke]. Konsilium Medikum – Consilium medikum, 8, 96-101 [in Russian].

Published

2019-04-10

How to Cite

Kozyolkin, O. A., Medvedkova, S. O., & Kuznietsov, A. A. (2019). EFFICIENCY OF NEUROMETABOLIC THERAPY AMONG THE PATIENTS WITH ISCHEMIC HEMISPHERIC STROKE IN RECOVERY PERIOD. Bulletin of Scientific Research, (1), 93–96. https://doi.org/10.11603/2415-8798.2019.1.9939

Issue

Section

NEUROLOGY AND PSYCHIATRY